2015-004702-42: A clinical trial in patients with the liver disease caused by the hepatitis C virus for assessment of safety and efficacy of one injection of test product RG-101 given in combination with test product GSK2878175 that is to be taken by mouth once daily for 6, 9, or 12 weeks |
|
|
| Completed | 2 | 24 | Europe | RG-101, GSK2878175, Solution for injection, Tablet | Regulus Therapeutics Inc., Regulus Therapeutics Inc. | Treatment Naïve, Genotype 1 and 3, Chronic Hepatitis C Patients, Liver disease caused by the hepatitis C virus, Genotype 1 and 3, Diseases [C] - Virus Diseases [C02] | | | | |
